Preclinical services to maximize pharmaceutical success

With more than 20 years of experience in developing and applying preclinical models, we specialize in delivering cutting-edge in vivo research services to accelerate drug development across multiple therapeutic areas.

Our mission is to support biotech and pharmaceutical partners by providing reliable, scientifically rigorous, and adaptative preclinical models that bring translational value. Our expertise lies not only in model development but in designing studies that bring out the full potential of your drug. We understand the complexities of translational research and know how to evaluate your drug under the optimal conditions for success—so you can move forward with clarity and confidence.

Backed by a solid scientific foundation in the in vivo pharmacology of infectious and blood-related diseases, our portfolio includes validated models and tailored study designs that reflect real-world disease dynamics.

Explore how TAD can become a
strategic partner in your R&D journey: